Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Bun-Hee | - |
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Kim, Tae-Woo | - |
dc.contributor.author | Lee, Heon-Jeong | - |
dc.contributor.author | Yoon, Ho-Kyoung | - |
dc.contributor.author | Park, Young-Min | - |
dc.date.accessioned | 2021-09-06T10:27:58Z | - |
dc.date.available | 2021-09-06T10:27:58Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.issn | 1323-1316 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/106128 | - |
dc.description.abstract | Aim: Amisulpride at low dosages enhances dopaminergic neurotransmission by preferentially blocking presynaptic D2/D3 receptors. Thus, low dosages of amisulpride are expected not to increase prolactin levels. The aim of this study was to examine whether low dosages of amisulpride can increase serum levels of prolactin or not clinically in Korean patients. Method: Serum prolactin levels were measured in 20 Korean patients (12 men and eight women) with various diagnoses who were treated with less than 300 mg of amisulpride per day. Results: The mean dosage of amisulpride was 195.0 +/- 51.0 mg/day, and serum level of prolactin was 76.1 +/- 43.4 ng/mL. The prolactin level was significantly higher in women (110.7 +/- 49.3 ng/mL) than in men (53.1 +/- 15.9 ng/mL) after administering amisulpride (P = 0.021), while the dosage of amisulpride did not differ significantly between men (200.0 +/- 42.6 mg/day) and women (187.5 +/- 64.1 mg/day) (P = 0.576). Conclusions: The low dosages of amisulpride elevate serum prolactin level in the majority of patients. This finding indicates that the dose-reduction of amisulpride has little effect to relieve amisulpride-induced hyperprolactinemia at therapeutic dosages. Clinicians should monitor serum prolactin level even when low dosages of amisulpride are administered. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | RECEPTOR OCCUPANCY | - |
dc.subject | RISPERIDONE | - |
dc.subject | SCHIZOPHRENIA | - |
dc.subject | DISORDERS | - |
dc.title | Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Heon-Jeong | - |
dc.contributor.affiliatedAuthor | Yoon, Ho-Kyoung | - |
dc.identifier.doi | 10.1111/j.1440-1819.2011.02296.x | - |
dc.identifier.scopusid | 2-s2.0-84862950065 | - |
dc.identifier.wosid | 000299208600009 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY AND CLINICAL NEUROSCIENCES, v.66, no.1, pp.69 - 73 | - |
dc.relation.isPartOf | PSYCHIATRY AND CLINICAL NEUROSCIENCES | - |
dc.citation.title | PSYCHIATRY AND CLINICAL NEUROSCIENCES | - |
dc.citation.volume | 66 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 69 | - |
dc.citation.endPage | 73 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | RECEPTOR OCCUPANCY | - |
dc.subject.keywordPlus | RISPERIDONE | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | DISORDERS | - |
dc.subject.keywordAuthor | amisulpride | - |
dc.subject.keywordAuthor | antipsychotics | - |
dc.subject.keywordAuthor | hyperprolactinemia | - |
dc.subject.keywordAuthor | prolactin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.